about
A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.A review of the associations between single nucleotide polymorphisms in taste receptors, eating behaviors, and health.Two sisters with Mayer-Rokitansky-Küster-Hauser syndrome and serous adenocarcinoma of the ovary.Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.Lifestyle genomics and the metabolic syndrome: A review of genetic variants that influence response to diet and exercise interventions.A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyDoes adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group studyOverexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group StudyDicer1 Phosphomimetic Promotes Tumor Progression and Dissemination
P50
Q35216723-6E1B5508-C138-4327-A0E8-F3C457B8B0CCQ38211462-6FEA9DBA-9655-4A85-A6CB-4A5490C8C27AQ38849704-35DDB5B5-0543-4D50-B9AF-83A656CB9AECQ41180126-54C168A2-103A-4BD9-881F-6997AFA5A29FQ47956425-089E7F80-7545-488C-BBD3-D0654F27BFF3Q52699706-A4DA9A96-65F7-4532-B9F6-94F438E279F2Q90763649-F1AC3B59-AD7F-4ACF-977C-2B95A0648E3BQ91086979-D01A9FC8-C6AD-47BD-95D7-FEC49B588D7FQ92019228-1F553A0D-FACE-43D2-85C4-3F5A5D36378DQ92635164-7F292635-4A32-403C-AC56-5D63E65194CC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David G Mutch
@ast
David G Mutch
@en
David G Mutch
@es
David G Mutch
@nl
David G Mutch
@sl
type
label
David G Mutch
@ast
David G Mutch
@en
David G Mutch
@es
David G Mutch
@nl
David G Mutch
@sl
prefLabel
David G Mutch
@ast
David G Mutch
@en
David G Mutch
@es
David G Mutch
@nl
David G Mutch
@sl
P106
P21
P31
P496
0000-0002-6921-1581